Merck (MRK) Net Income towards Common Stockholders (2009 - 2026)
Merck (MRK) reported Net Income towards Common Stockholders of $5.07 billion for Q3 2026, down 12.4% from $5.79 billion a year earlier.
Powered by 
Analysis
Merck (MRK) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Merck's Net Income towards Common Stockholders came in at $2.45 billion, down 87.1% year-over-year; for FY2025, it was $18.25 billion, up 6.6% from FY2024.
- Net Income towards Common Stockholders has a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
- By year, Net Income towards Common Stockholders came in at $17.12 billion in FY2024, $365 million in FY2023 (-97.5%), $14.52 billion in FY2022 (+11.3%) and $13.05 billion in FY2021 (+84.6%).
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$5.98 billion in Q2 2023 and a high of $5.79 billion in Q3 2025.
- Year over year, Net Income towards Common Stockholders gained in two of the last five quarters, with growth averaging 7.6%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q2 2022 (growth of 155.3%); the low point was Q1 2023 (a decline of 34.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at -$1.34 billion (Q2 2026), -$4.24 billion (Q1 2026) and $2.96 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.07 Bn |
| Jun 30, 2026 | -1.34 Bn |
| Mar 31, 2026 | -4.24 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 5.79 Bn |
| Jun 30, 2025 | 4.43 Bn |
| Mar 31, 2025 | 5.08 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 3.16 Bn |
| Jun 30, 2024 | 5.46 Bn |
| Mar 31, 2024 | 4.76 Bn |
| Dec 31, 2023 | -1.23 Bn |
| Sep 30, 2023 | 4.75 Bn |
| Jun 30, 2023 | -5.98 Bn |
| Mar 31, 2023 | 2.82 Bn |
| Dec 31, 2022 | 3.02 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.94 Bn |
| Mar 31, 2022 | 4.31 Bn |
| Dec 31, 2021 | 3.76 Bn |
API Access
Merck Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();